Disease | lymphoproliferative disorders |
Phenotype | C0003873|rheumatoid arthritis |
Sentences | 4 |
PubMedID- 23269079 | Successful treatment of immunodeficiency-associated ebv-negative lymphoproliferative disorders in rheumatoid arthritis by methotrexate withdrawal and prevention of its relapse by rituximab administration. |
PubMedID- 21830047 | rheumatoid arthritis complicated with immunodeficiency-associated lymphoproliferative disorders during treatment with adalimumab. |
PubMedID- 23560463 | Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, epstein-barr virus, and clonality are important predictors of disease progression and regression. |
PubMedID- 24498893 | Clinical characteristics and incidence of methotrexate-related lymphoproliferative disorders of patients with rheumatoid arthritis. |
Page: 1